Source: International Congress 2018 – Pleural effusions, infections and tumours
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Lioumpas (Athens, Greece), A. Panagiotou (Athens, Greece), K. Bouboulis (Athens, Greece), I. Samiotis (Athens, Greece), I. Stamatatos (Athens, Greece), D. Mylonaki (Athens, Greece), S. Zaragkas (Athens, Greece), N. Tzatzadakis (Athens, Greece). Treatment of empyema thoracis in HIV-infected patients in the era of antiretroviral therapy: a thoracic surgeon's point of view. 2567

Member's Comments

No comment yet.

Related content which might interest you: Development and improvement of single-stage surgical treatments of patients with spondylitis and pulmonary and pleural TB Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Clinicoradiological profile and treatment outcome of empyema thoracis patients Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Consecutive surgical treatment for bilateral fibro-cavernous pulmonary TB Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Empyema thoracis: therapeutic management and outcome Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Iterative therapeutic thoracocentesis as the first-line treatment of complicated parapneumonic effusion: An observational study of 79 consecutive cases Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006 Surgical treatment of pleural infections: the surgeon's point of view Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=181 Year: 2004 Empyema thoracis in children: role of ultrasonography in therapeutic intervention Source: Annual Congress 2009 - Thoracoscopy and solitary pulmonary nodules Year: 2009 Does standardized medical treatment for parapneumonic empyema (PE) in children reduces the need for surgical intervention? Source: Annual Congress 2013 –Pulmonary infection in children: diagnosis and long-term effects Year: 2013 Clinical experience in surgical therapy of 184 patients with bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 626s Year: 2004 Efficacy of medical thoracoscopy in thoracic empyema treatment Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity Year: 2020 Extrapleural plombage with silicone filling in stage-by-stage surgical treatment for disseminated pulmonary TB Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Peripheral neuropathy in XDR-TB patients on second line anti-tubercular therapy Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Surgical treatment in parapneumonic effusion: what's new? Source: Annual Congress 2007 - Parapneumonic effusion: diagnosis and treatment are a matter of timing Year: 2007 Tuberculous empyema thoracis surgical perspective. A tertiary care center experience Source: Annual Congress 2011 - Pleural diseases and pneumothorax Year: 2011 Current indications for decortication in the treatment of empyema in children Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood Year: 2009 Design of tuberculosis treatment regimens for drug-resistant and intolerant patients – patient and clinician perspectives Source: International Congress 2018 – CC4 Tuberculosis Year: 2018 Our clinical experience in surgical therapy of patients with bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 344s Year: 2002 Long-term outcome of extrapleural pneumothorax treatment of a patient with pulmonary TB – a case report which brings us back in time Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of multidrug-resistant tuberculosis Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016